New York, February 8 -- A new drug that aims to stop the creation of serotonin hormone in the gut could possibly help, and treat osteoporosis, finds a novel U.S. study.
Osteoporosis is a bone-thinning disease that may result in fractures, and numerous types of drugs are available to prevent the condition.
The researchers from the Columbia University Medical Center who initiated the study found that the new drug that was initially developed to treat the irritable bowel syndrome (IBS), reversed bone loss, and also cured the disease in some cases.
